HS-20093: Clinical Trials

6 trials of HS-20093, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 not yet recruiting, 1 unknown, 1 withdrawn. 6 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Recruiting 3, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 11Not yet recruiting 1

Follow HS-20093: new trials by email Literature Review of HS-20093 trials Research Report on HS-20093

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer
HRS-2329 Tablet, Nimotuzumab, HS-20093 - Pancreatic Cancer, RAS Mutations or Amplifications
Phase 1 / Phase 2Not yet recruitingZhejiang University802026-08-152026-08-31
ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer
HS-20093 - Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Phase 2WithdrawnHansoh BioMedical R&D Company2024-11-302024-03-04
HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors
HS-20093 - Advanced Solid Tumor
Phase 2RecruitingHansoh BioMedical R&D Company2202024-02-062024-12-02
ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors
HS-20093 - Metastasis Castration Resistant Prostate Cancer(mCRPC)
Phase 2UnknownHansoh BioMedical R&D Company1202024-01-182024-08-20
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
HS-20093 - Head and Neck Squamous Cell Carcinoma
Phase 2RecruitingHansoh BioMedical R&D Company1702023-12-182024-08-20
ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas
HS-20093 - Osteosarcoma, Sarcoma
Phase 2RecruitingHansoh BioMedical R&D Company1702023-06-082024-08-23

Conditions studied

Esophageal Neoplasms (1)  ·  Osteosarcoma (1)  ·  Pancreatic Neoplasms (1)  ·  Sarcoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Hansoh BioMedical R&D Company (5)  ·  Zhejiang University (1)

Countries

China (5)

Top investigators

Wei Guo, MD (1)